| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |